Additionally, NLRP6 deficiency has been linked to intestinal inflammation, hyperplasia, and worsened colitis in mice, suggesting that disruptions in the inflammasome pathway may increase susceptibility to IBD [29]. This evidence concerns the gene NLRP6 and inflammatory bowel disease.